5B2T image
Deposition Date 2016-02-02
Release Date 2016-03-23
Last Version Date 2023-11-08
Entry Detail
PDB ID:
5B2T
Title:
Crystal structure of the Streptococcus pyogenes Cas9 VRER variant in complex with sgRNA and target DNA (TGCG PAM)
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.22
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polyribonucleotide
Molecule:Guide RNA
Chain IDs:A
Chain Length:81
Number of Molecules:1
Biological Source:Streptococcus pyogenes
Polymer Type:polypeptide(L)
Molecule:CRISPR-associated endonuclease Cas9
Gene (Uniprot):cas9
Mutations:D10A, C80L, C574E, H840A, D1135V, G1218R, R1335E, T1337R
Chain IDs:B
Chain Length:1372
Number of Molecules:1
Biological Source:Streptococcus pyogenes serotype M1
Polymer Type:polydeoxyribonucleotide
Molecule:Target DNA
Chain IDs:C
Chain Length:28
Number of Molecules:1
Biological Source:Streptococcus pyogenes
Polymer Type:polydeoxyribonucleotide
Molecule:Non-target DNA, DNA (5'-D(*TP*GP*CP*GP*AP*TP*TP*G)-3')
Chain IDs:D
Chain Length:8
Number of Molecules:1
Biological Source:Streptococcus pyogenes
Primary Citation
Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9
Mol.Cell 61 886 894 (2016)
PMID: 26990991 DOI: 10.1016/j.molcel.2016.02.018

Abstact

The RNA-guided endonuclease Cas9 cleaves double-stranded DNA targets bearing a PAM (protospacer adjacent motif) and complementarity to the guide RNA. A recent study showed that, whereas wild-type Streptococcus pyogenes Cas9 (SpCas9) recognizes the 5'-NGG-3' PAM, the engineered VQR, EQR, and VRER SpCas9 variants recognize the 5'-NGA-3', 5'-NGAG-3', and 5'-NGCG-3' PAMs, respectively, thus expanding the targetable sequences in Cas9-mediated genome editing applications. Here, we present the high-resolution crystal structures of the three SpCas9 variants in complexes with a single-guide RNA and its altered PAM-containing, partially double-stranded DNA targets. A structural comparison of the three SpCas9 variants with wild-type SpCas9 revealed that the multiple mutations synergistically induce an unexpected displacement in the phosphodiester backbone of the PAM duplex, thereby allowing the SpCas9 variants to directly recognize the altered PAM nucleotides. Our findings explain the altered PAM specificities of the SpCas9 variants and establish a framework for further rational engineering of CRISPR-Cas9.

Legend

Protein

Chemical

Disease

Primary Citation of related structures